# Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD

> **NCT03725631** · NA · UNKNOWN · sponsor: **Korea University Guro Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Nonalcoholic Fatty Liver
- Nonalcoholic Steatohepatitis

## Interventions

- **DIAGNOSTIC_TEST:** Imaging and serologic evaluation of fibrosis and steatosis

## Key facts

- **NCT ID:** NCT03725631
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03725631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03725631, "Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03725631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*